Understanding Transthyretin Amyloid Cardiomyopathy

Stormi Gale

Speaker:
Stormi Gale, PharmD, BCPS, BCCP, FHFSA
Cardiology Clinical Pharmacy Specialist
Atrium Health Carolinas Medical Center

Patient Panelist:
Sean Riley

 

 

 

 

 

 

 

 

 

Disclosure (s):
The speaker, panelist, and the reviewers who contributed to this activity have no relevant financial conflicts of interest to disclose.

 

Acknowledgements: This CE presentation is supported by an unrestricted educational grant from BridgeBio.

Type of Activity: Knowledge-based

Learning Objectives:

  • Explain the underlying pathophysiology of cardiac amyloidosis, with a focus on distinguishing between the most common types
  • Identify the key diagnostic criteria and tools used in the detection of cardiac amyloidosis
  • Discuss the current management strategies and emerging therapeutic options for cardiac amyloidosis
Target Audience: Pharmacists Fee: Free
Release Date: November 25, 2024 Expiration Date: November 25, 2026
Estimated time to complete: 1.0 hours CE: 1.0 contact hours (0.1 CEUs)

Go to activity

ACPE logo

How to Earn Credit:

Participants must complete the activity as described below in the Continuing Education Statement. To answer the post-test questions, click on your selected choice for each answer then proceed to the next question. After completing the post-test, you will receive your final score. You will have a chance to review the correct answers and answer rationales. After successfully completing the post-test, you will proceed to complete the activity evaluation to claim your CE credit. All CE credits will be uploaded to CPE Monitor ™.

Hardware/Software and Internet Requirements can be found at https://pharmacyce.uic.edu/moodle/.

Provider Contact Information:
For general information or questions,  email the Office of Continuing Education and Meeting Services at pharmce@uic.edu. Copyright © 2024– The Board of Trustees of the University of Illinois. All rights reserved. Reproduction in whole or in part without permission is prohibited. Privacy Policy

NASP Disclaimer: The Specialty Pharmacy Certification Board (SPCB) develops and oversees certification programs for specialty pharmacists and licensed pharmacists who work in a capacity related to specialty pharmacy and meet the eligibility requirements in the candidate handbook, implements policies and procedures for these certification programs, and oversees the development of the certification examination(s). The SPCB retains autonomy over all certification program policies and decisions. It is important to note that as the CSP’s governing board, the SPCB does not accredit, approve, endorse, or recommend any education or training programs and/or products designed or intended to prepare candidates for certification. SPCB has no involvement in the development or delivery of such programs or products.